The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

These include, but are not limited to, the big three drug middlemen known as pharmacy benefit managers (PBMs). According to ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...

He added that the law fails to "rein in abusive practices" from drug-pricing middlemen called pharmacy benefit managers and ...

Denouncing the $557 billion industry as “horrible middlemen,” responsible for—and “rich as hell” from— America’s incomparably high prescription drug prices, Trump vowed to get rid of ...